Trial Profile
Glucose-lowering effect of insulin glargine 300 U/ml in Japanese type 2 diabetic patients treated with basal-bolus insulin therapy
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Jun 2016
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 31 May 2016 Status changed from recruiting to completed.
- 20 Oct 2015 New trial record